Xiaoyu Xi

机构：China Pharmaceutical University, Beijing University of Chinese Medicine · ORCID：0000-0003-2144-0067

发表论文 83 篇 · 总被引 1040 次 · h-index 20

代表论文

• The anchor design of anchor-based method to determine the minimal clinically important difference: a systematic review (2023 · Health and Quality of Life Outcomes · 被引 58)
• Factors influencing clinical pharmacists’ integration into the clinical multidisciplinary care team (2023 · Frontiers in Pharmacology · 被引 12)
• Multilevel medical insurance mitigate health cost inequality due to air pollution: Evidence from China (2024 · International Journal for Equity in Health · 被引 7)
• Current status of treatment and disease burden of a cohort of hemophilia B in China (2024 · Frontiers in Public Health · 被引 7)
• Public preferences for online medical consultations in China: a discrete choice experiment (2023 · Frontiers in Public Health · 被引 6)
• Impact of digital integrated health platforms on diabetes management: evidence from Tianjin, China (2025 · BMC Health Services Research · 被引 5)